QEII Halifax Infirmary Emergency Department is working with reduced space, which may lead to delays for those with less urgent concerns. Learn more here.

Nova Scotia Health has made changes to parking and the main entrance of the QEII Halifax Infirmary. Learn more.

Erythropoieis-stimulating Agents (ESAs) for People With Chronic Kidney Disease (CKD) and Active Cancer or a History of Cancer or Stroke

Categories

Kidneys

Cancer

Medications

Attachment

Last Update

September 1, 2024

Extension

.pdf

Print Code

WQ85-2217

Language

English

Creator

Renal Program

If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.

Employee Resources